DEUTSCHE BANK AG\ - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 20 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$90,000
-21.1%
72,425
+1.9%
0.00%
Q4 2021$114,000
-72.6%
71,047
-44.4%
0.00%
Q3 2021$416,000
-5.2%
127,749
+83.9%
0.00%
Q2 2021$439,000
+3890.9%
69,454
+1473.5%
0.00%
Q3 2020$11,000
+10.0%
4,414
-31.0%
0.00%
Q4 2019$10,0006,394
+2031.3%
0.00%
Q2 2019$0300
+4185.7%
0.00%
Q3 2018$0
-100.0%
7
-99.7%
0.00%
Q2 2018$4,0002,2070.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Ahrens Investment Partners LLC 10,000$26,0000.01%
PNC FINANCIAL SERVICES GROUP, INC. 66$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 100$00.00%
GEODE CAPITAL MANAGEMENT, LLC 89,903$229,0000.00%
DEUTSCHE BANK AG\ 300$00.00%
MORGAN STANLEY 1,910$5,0000.00%
BlackRock Inc. 669$2,0000.00%
Citadel Advisors 17,000$43,0000.00%
Citadel Advisors 10,298$26,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders